Journal of Clinical Trials

Journal of Clinical Trials
Open Access

ISSN: 2167-0870

+44 20 3868 9735

Journal of Clinical Trials : Citations & Metrics Report

Articles published in Journal of Clinical Trials have been cited by esteemed scholars and scientists all around the world. Journal of Clinical Trials has got h-index 17, which means every article in Journal of Clinical Trials has got 17 average citations.

Following are the list of articles that have cited the articles published in Journal of Clinical Trials.

  2021 2020 2019 2018 2017

Year wise published articles

79 78 38 20 35

Year wise citations received

171 166 120 127 143
Journal total citations count 1222
Journal impact factor 2.76
Journal 5 years impact factor 3.07
Journal cite score 3.14
Journal h-index 17
Journal h-index since 2017 13
Important citations

The biomarkers for acute kidney injury: a clear road ahead?

Acute kidney injury and renal replacement therapy

Severe acute kidney injury in neonates with necrotizing enterocolitis: risk factors and outcomes

Clinical phenotypes of acute kidney injury are associated with unique outcomes in critically ill septic children.

acute kidney injury after in-hospital cardiac arrest

Modern approach to the diagnosis of cardiovascular disorders newborns at perinatal risk in the neonatal period

Targeting the ecirp/trem-1 interaction with a small molecule inhibitor improves cardiac dysfunction in neonatal sepsis

Early detection of significant congenital heart disease: the contribution of fetal cardiac ultrasound and newborn pulse oximetry screening

Fifteen-minute consultation: how to spot serious heart disease in the newborn

Novel breast cancer brain metastasis patient-derived orthotopic xenograft model for preclinical studies.

childhood erythrodermic lichen planus pemphigoides after nonavalent human papillomavirus vaccination

Current challenges in clinical trials

current challenges in clinical trials

Probiotic lactobacilli: can be a remediating supplement for pandemic covid-19. a review

Potential roles for probiotics in the treatment of covid-19 patients and prevention of complications associated with increased antibiotic use

Biological aspects of hcc

Relationships between indices of tumor aggressiveness in hepatocellular carcinoma.

tumor multifocality and serum albumin levels can identify groups of patients with hepatocellular carcinoma and portal vein thrombosis having distinct survival outcomes

Portal vein thrombosis and markers of inflammation in hepatocellular carcinoma

Utility-based dose selection for phase ii dose-finding studies

Relevant Topics